Molecular alterations in colitis-associated colorectal neoplasia: Study from a low prevalence area using magnifying chromo colonoscopy

Journal of Crohn's and Colitis

Volumn 6, Issue 6, 2012, Pages 647-654

  Shivakumar, Bhadravathi Marigowda ^a,b   Kumar, Balasubramanian Lakshman ^a,b   Bhat, Ganesh ^a   Suvarna, Deepak ^a   Rao, Lakshmi ^a   Pai, C Ganesh ^a   Satyamoorthy, Kapaettu ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b MANIPAL UNIVERSITY   (India)

Author keywords

Colorectal neoplasia; Magnifying chromo colonoscopy; Microsatellite instability; P53; Ulcerative colitis

Indexed keywords

B RAF KINASE; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLON BIOPSY; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAGNIFYING CHROMO COLONOSCOPY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADENOCARCINOMA; ADENOMA; ADULT; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; GENETIC MARKERS; HUMANS; INDIA; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 84862190172     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.11.013     Document Type: Article

References (48)

1. Sung J.J.Y., Lau J.Y.W., Goh K.L., Leung W.K. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005, 6:871-876.
2. Ouyang Q., Tandon R., Goh K.L., Pan G.Z., Fock K.M., Fiocchi C., et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol. 2006, 21:1772-1782.
3. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
4. Kim B.J., Yang S.K., Kim J.S., Jeen Y.T., Choi H., Han D.S., et al. Trends of ulcerative colitis associated colorectal cancer in Korea: A KASID study. J Gastroenterol Hepatol. 2009, 24:667-671.
5. Kochhar R., Goenka M.K., Kaushik S.P., Gupta N.M., Nagi B., Mehta S.K. Colorectal carcinoma in Indian patients with idiopathic ulcerative colitis. Eur J Cancer Prev. 1992, 1:293-296.
6. Ray G. Inflammatory bowel disease in India-changing paradigms. Int J Colorectal Dis 2011, 26:1-10.
7. Sung J.J.Y., Lau J.Y.W., Young G.P., Sano Y., Chiu H.M., Byeon J.S., et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008, 57:1166-1176.
8. Venkataraman S., Mohan V., Ramakrishna B.S., Peter S., Chacko A., Chandy G., et al. Risk of colorectal cancer in ulcerative colitis in India. J Gastroenterol Hepatol. 2005, 20:705-709.
9. Gupta R.B., Harpaz N., Itzkowitz S., Hossain S., Matula S., Kornbluth A., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007, 133:1099-1105.
10. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology.
11. Carethers J.M. The cellular and molecular pathogenesis of colorectal cancer. Gastroenterol Clin North Am 1996, 25:737-754.
12. Grady W.M., Markowitz S.D. Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 2002, 3:101-128.
13. Ali R., Affendi R., Dooley C., Comber H., Newell J., Egan L.J. Clinical Features, Treatment, and Survival of Patients with Colorectal Cancer with or without Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2011, 9(7):584-589.
14. Loftus E.V. Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis. Gastroenterol Clin North Am 2006, 35:517-531.
15. Riddell R.H., Goldman H., Ransohoff D.F., Appelman H.D., Fenoglio C.M., Haggitt R.C., et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983, 14:931-968.
16. Cairns S.R., Scholefield J.H., Steele R.J., Dunlop M.G., Thomas H.J.W., Evans G.D., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010, 59:666-689.
17. Farraye F.A., Odze R.D., Eaden J., Itzkowitz S.H. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010, 138:738-745.
18. Itzkowitz S.H., Present D.H. Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:314-321.
19. Kiesslich R., Neurath M.F. Chromoendoscopy: an evolving standard in surveillance for ulcerative colitis. Inflamm Bowel Dis 2004, 10:695-696.
20. Matsumoto T., Iwao Y., Igarashi M., Watanabe K., Otsuka K., Watanabe T., et al. Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long standing ulcerative colitis. Inflamm Bowel Dis. 2008, 14:259-264.
21. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
22. Feagins L.A., Souza R.F., Spechler S.J. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 2009, 6:297-305.
23. Itzkowitz S.H. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 2006, 35:553-571.
24. Fujiwara I., Yashiro M., Kubo N., Maeda K., Hirakawa K. Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway. Dis Colon Rectum. 2008, 51:1387-1394.
25. Pandey V., Prabhu J.S., Payal K., Rajan V., Deepak C., Barde S., et al. Assessment of microsatellite instability in colorectal carcinoma at an Indian center. Int J Colorectal Dis. 2007, 22:777-782.
26. Suszuki H., Harpaz N., Tarmin L., Yin J., Jiang H.Y., Bell J.D., et al. Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res. 1994, 54:4841-4844.
27. Burmer G.C., Levine D.S., Kulander B.G., Haggitt R.C., Rubin C.E., Rabinovitch P.S. c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology. 1990, 99:416-420.
28. Tomlinson I., Ilyas M., Johnson V., Davies A., Clark G., Talbot I., et al. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer. J Pathol. 1998, 184:148-152.
29. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., et al. Mutations of the BRAF gene in human cancer. Nature. 2002, 417:949-954.
30. Satyamoorthy K., Li G., Gerrero M.R., Brose M.S., Volpe P., Weber B.L., et al. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 2003, 63:756-759.
31. Iacopetta B. TP53 mutation in colorectal cancer. Hum Mutat 2003, 21:271-276.
32. Soong R., Powell B., Elsaleh H., Gnanasampanthan G., Smith D.R., Goh H.S., et al. Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma: influence of tumour site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer. 2000, 36:2053-2060.
33. Burmer G.C., Rabinovitch P.S., Haggitt R.C., Crispin D.A., Brentnall T.A., Kolli V.R., et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology. 1992, 103:1602-1610.
34. Hurlstone D.P., Sanders D.S., Lobo A.J., McAlindon M.E., Cross S.S. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy. 2005, 37:1186-1192.
35. Rutter M.D., Saunders B.P., Schofield G., Forbes A., Price A.B., Talbot I.C. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut. 2004, 53:256-260.
36. Kudo S., Hirota S., Nakajima T., Hosobe S., Kusaka H., Kobayashi T., et al. Colorectal tumours and pit pattern. J Clin Pathol. 1994, 47:880-885.
37. Berg K.D., Glaser C.L., Thompson R.E., Hamilton S.R., Griffin C.A., Eshleman J.R. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn. 2000, 2:20-28.
38. Aust D.E., Haase M., Dobryden L., Markwarth A., Löhrs U., Wittekind C., et al. Mutations of the BRAF gene in ulcerative colitis-related colorectal carcinoma. Int J Cancer. 2005, 115:673-677.
39. Cohen Y., Goldenberg-Cohen N., Parrella P., Chowers I., Merbs S.L., Pe'er J., et al. Lack of BRAF mutation in primary uveal melanoma. Invest Ophthalmol Vis Sci. 2003, 44:2876-2878.
40. Brentnall T.A., Crispin D.A., Bronner M.P., Cherian S.P., Hueffed M., Rabinovitch P.S., et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res. 1996, 56:1237-1240.
41. Umetani N., Sasaki S., Watanabe T., Shinozaki M., Matsuda K., Ishigami H., et al. Genetic Alterations in Ulcerative Colitis associated Neoplasia Focusing on APC, K ras Gene and Microsatellite Instability. Jpn J Cancer Res. 1999, 90:1081-1087.
42. Brentnall T.A., Crispin D.A., Rabinovitch P.S., Haggitt R.C., Rubin C.E., Stevens A.C., et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994, 107:369-378.
43. Chaubert P., Benhattar J., Saraga E., Costa J. K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol. 1994, 144:767-775.
44. Holzmann K., Klump B., Borchard F., Hsieh C.J., Kühn A., Gaco V., et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer. 1998, 76:1-6.
45. Kern S.E., Redston M., Seymour A.B., Caldas C., Powell S.M., Konacki S., et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology. 1994, 107:420-428.
46. Chen J., Compton C., Cheng E., Fromowitz F., Viola M.V. c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology. 1992, 102:1983-1987.
47. Fujii S., Fujimori T., Chiba T., Terano A. Efficacy of surveillance and molecular markers for detection of ulcerative colitis-associated colorectal neoplasia. J Gastroenterol. 2003, 38:1117-1125.
48. Velayos F.S., Loftus E.V., Jess T., Harmsen W.S., Bida J., Zinsmeister A.R., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology. 2006, 130:1941-1949.